Artemisinin-naphthoquine combination therapy for uncomplicated pediatric malaria: A tolerability, safety, and preliminary efficacy study

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 5, 2012, Pages 2465-2471

  Benjamin, John ^a   Moore, Brioni ^b   Lee, Sook Ting ^b   Senn, Michèle ^a   Griffin, Susan ^a   Lautu, Dulci ^a   Salman, Sam ^b   Siba, Peter ^a   Mueller, Ivo ^c,d   Davis, Timothy M E ^b  

^a PAPUA NEW GUINEA INSTITUTE OF MEDICAL RESEARCH   (Papua New Guinea)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^d CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTEMISININ; NAPHTHOQUINE; UNCLASSIFIED DRUG; WATER;

ABNORMAL LABORATORY RESULT; ARTICLE; BIOCHEMISTRY; BLOOD PRESSURE; CHILD; CLINICAL ARTICLE; DISEASE TRANSMISSION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ELECTROCARDIOGRAPHY; FEMALE; FEVER; FOLLOW UP; HEARING; HUMAN; MALARIA; MALARIA FALCIPARUM; MALE; MILK; PAPUA NEW GUINEA; PARASITE CLEARANCE; PARASITEMIA; PLASMODIUM VIVAX MALARIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PULSE RATE; QT DISPERSION; QT INTERVAL; RECURRENT DISEASE; REINFECTION; SIDE EFFECT;

ANTIMALARIALS; ARTEMISININS; BLOOD PRESSURE; CHILD; DRUG ADMINISTRATION SCHEDULE; DRUG TOXICITY; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEARING; HUMANS; MALARIA, FALCIPARUM; MALARIA, VIVAX; MALE; NAPHTHOQUINONES; PAPUA NEW GUINEA; RECURRENCE; TREATMENT OUTCOME;

EID: 84860186305     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.06248-11     Document Type: Article

References (32)

1. Batty KT, et al. 2012. Artemisinin-naphthoquine combination therapy for uncomplicated pediatric malaria: a pharmacokinetic study. Antimicrob. Agents Chemother. 56:2472-2484.
2. Bustos MD, Gay F, Diquet B, Thomare P, Warot D. 1994. The pharmacokinetics and electrocardiographic effects of chloroquine in healthy subjects. Trop. Med. Parasitol. 45:83-86. (Pubitemid 24209644)
3. Chen PQ, et al. 1994. The infectivity of gametocytes of Plasmodium falciparum from patients treated with artemisinin. Chin. Med. J. 107:709-711.
4. Cook JA, Randinitis EJ, Bramson CR, Wesche DL. 2006. Lack of a pharmacokinetic interaction between azithromycin and chloroquine. Am. J. Trop. Med. Hyg. 74:407-412. (Pubitemid 46774361)
5. Dondorp AM, et al. 2010. Artemisinin resistance: current status and scenarios for containment. Nat. Rev. Microbiol. 8:272-280.
6. Genton B, et al. 2008. Plasmodium vivax and mixed infections are associated with severe malaria in children: a prospective cohort study from Papua New Guinea. PLoS Med. 5:e127.
7. Gorman JG, Kidson C. 1962. Distribution pattern of an inherited trait, red cell enzyme deficiency, in New Guinea and New Britain. Am. J. Phys. Anthropol. 20:347-356.
8. Hassan Alin M, Ashton M, Kihamia CM, Mtey GJ, Bjorkman A. 1996. Multiple dose pharmacokinetics of oral artemisinin and comparison of its efficacy with that of oral artesunate in falciparum malaria patients. Trans. R. Soc. Trop. Med. Hyg. 90:61-65. (Pubitemid 26069449)
9. Hombhanje FW, Huang Q. 2010. Artemisinin-naphthoquine combination (ARCO): an overview of progress. Pharmaceuticals 3:3581-3593.
10. Hombhanje FW, et al. 2009. Artemisinin-naphthoquine combination (ARCO) therapy for uncomplicated falciparum malaria in adults of Papua New Guinea: a preliminary report on safety and efficacy. Malar. J. 8:196.
11. Karunajeewa HA, et al. 2008. A trial of combination antimalarial therapies in children from Papua New Guinea. N. Engl. J. Med. 359:2545-2557.
12. Krudsood S, et al. 2003. Comparative clinical trial of two-fixed combinations dihydroartemisinin-napthoquine-trimethoprim (DNP) and artemether-lumefantrine (Coartem/Riamet) in the treatment of acute uncomplicated falciparum malaria in Thailand. Southeast Asian J. Trop. Med. Public Health 34:316-321. (Pubitemid 37141264)
13. Kunming Pharmaceutical Corporation. 2006. Instruction for use of compound naphthoquine phosphate tablets. Product information brochure. Kunming Pharmaceutical Corporation, Kunming, Yunnan Province, China.
14. Mackinnon MJ, Marsh K. 2010. The selection landscape of malaria parasites. Science 328:866-871.
15. Manning L, et al. 2011. Reference intervals for common laboratory tests in Melanesian children. Am. J. Trop. Med. Hyg. 85:50-54.
16. McIntosh HM, Olliaro P. 2000. Artemisinin derivatives for treating uncomplicated malaria. Cochrane Database Syst. Rev. 2000:CD000256.
17. Michon P, et al. 2007. The risk of malarial infections and disease in Papua New Guinean children. Am. J. Trop. Med. Hyg. 76:997-1008. (Pubitemid 351837856)
18. Mytton OT, et al. 2007. Electrocardiographic safety evaluation of dihydroartemisinin piperaquine in the treatment of uncomplicated falciparum malaria. Am. J. Trop. Med. Hyg. 77:447-450. (Pubitemid 351844317)
19. Nigerian-German Chemicals Plc. January 2012, accession date. Arco product information. Nigerian-German Chemicals Plc, Lagos, Nigeria. www.ngcplc.com/arco/index.html.
20. Nosten FH. 2010. Pyronaridine-artesunate for uncomplicated falciparum malaria. Lancet 375:1413-1414.
21. Papua New Guinea Department of Health. 2000. Standard treatment of common illnesses of children in Papua New Guinea, 7th ed. Government of Papua New Guinea, Port Moresby, New Guinea.
22. Pirozzo S, Papinczak T, Glasziou P. 2003. Whispered voice test for screening for hearing impairment in adults and children: systematic review. BMJ 327:967.
23. Price RN, et al. 1996. Effects of artemisinin derivatives on malaria transmissibility. Lancet 347:1654-1658. (Pubitemid 26177386)
24. Qu HY, et al. 2010. Single-dose safety, pharmacokinetics, and food effects studies of compound naphthoquine phosphate tablets in healthy volunteers. J. Clin. Pharmacol. 50:1310-1318.
25. Svensson US, Alin H, Karlsson MO, Bergqvist Y, Ashton M. 2002. Population pharmacokinetic and pharmacodynamic modelling of artemisinin and mefloquine enantiomers in patients with falciparum malaria. Eur. J. Clin. Pharmacol. 58:339-351. (Pubitemid 34983925)
26. Tun T, et al. 2009. Efficacy of oral single dose therapy with artemisininnaphthoquine phosphate in uncomplicated falciparum malaria. Acta Trop. 111:275-278.
27. Van Dorn CS, Johnson JN, Taggart NW, Thorkelson L, Ackerman MJ. 2011. QTc values among children and adolescents presenting to the emergency department. Pediatrics 128:e1395-e1401.
28. Wang JY, et al. 2004. Naphthoquine phosphate and its combination with artemisinine. Acta Trop. 89:375-381.
29. White NJ. 2007. Cardiotoxicity of antimalarial drugs. Lancet Infect. Dis. 7:549-558. (Pubitemid 47077715)
30. World Health Organization. 2000. Severe falciparum malaria. Trans. R. Soc. Trop. Med. Hyg. 94(Suppl. 1):S1-S90.
31. World Health Organization. 2003. Assessment and monitoring of antimalarial drug efficacy for the treatment of uncomplicated falciparum malaria. WHO/HTM/RBM/2003.50. World Health Organization, Geneva, Switzerland. http://whqlibdoc.who.int/hq/2003/WHO-HTM-RBM-2003.50.pdf.
32. World Health Organization. 2010. Guidelines for the treatment of malaria, 2nd ed. World Health Organization, Geneva, Switzerland.